Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multiple Sclerosis Healthy Subjects”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02511028
What this trial is testing

In Vivo Characterization of Inflammation With Ferumoxytol, an Ultrasmall Superparamagnetic Iron Oxide Nanoparticle, on 7 Tesla Magnetic Resonance Imaging

Who this might be right for
Multiple Sclerosis
National Institute of Neurological Disorders and Stroke (NINDS) 14
Early research (Phase 1)Study completedNCT04171310
What this trial is testing

Study of Excretion Balance and Pharmacokinetics of [14C]-SAR442168 in Healthy Male Subjects

Who this might be right for
Multiple Sclerosis
Sanofi 6
Not applicableStudy completedNCT02996084
What this trial is testing

MS PATHS Normative Sub-Study

Who this might be right for
Healthy Volunteer
Biogen 246
Early research (Phase 1)Study completedNCT02517788
What this trial is testing

Phase I BP Interferon (IFN) Beta-004

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Centre Hospitalier Universitaire Vaudois 24
Early research (Phase 1)Study completedNCT02442557
What this trial is testing

Safety and Dose-finding Study of DC-TAB in Healthy Subjects

Who this might be right for
Multiple Sclerosis
Delta Crystallon BV 76
Early research (Phase 1)Study completedNCT05181215
What this trial is testing

Bioequivalence Study of Bafiertam 190 mg and Vumerity® 462 mg Delayed-Release Capsules in Fasting Healthy Subjects

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Banner Life Sciences LLC 46
Not applicableEnrolling By InvitationNCT05162638
What this trial is testing

Immune Profiles in Multiple Sclerosis (MS) Patients and Healthy Volunteers Through Thoracic Duct Cannulation

Who this might be right for
Multiple SclerosisHealthy
University of Pennsylvania 24
Early research (Phase 1)UnknownNCT02364986
What this trial is testing

Immune- and miRNA-response to Recombinant Interferon Beta in Healthy Volunteers and Patients With Relapsing Remitting Multiple Sclerosis

Who this might be right for
Relapsing-remitting Multiple Sclerosis
PD Dr. Marcus Müller 50
Early research (Phase 1)Study completedNCT01431937
What this trial is testing

Assessment of Repeat Ascending Doses of GSK2018682 in Healthy Volunteers

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
GlaxoSmithKline 40
Not applicableStudy completedNCT00099307
What this trial is testing

Magnetic Resonance Imaging to Detect Brain Damage in Patients With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
National Institute of Neurological Disorders and Stroke (NINDS) 94
Early research (Phase 1)Study completedNCT01466322
What this trial is testing

Assess the Relative Bioavailability of Different Formulations of GSK2018682, a Sphingosine-1-phosphate Receptor Subtype 1 Agonist, in Healthy Volunteers.

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
GlaxoSmithKline 16
Early research (Phase 1)Ended earlyNCT00612872
What this trial is testing

Evaluation of [123I]CLINDE and SPECT as a Marker of Inflammation in Subjects With PD or AD and in Healthy Subjects

Who this might be right for
Parkinson DiseaseAlzheimer DiseaseHealthy Controls+1 more
Institute for Neurodegenerative Disorders 46
Early research (Phase 1)Study completedNCT02833142
What this trial is testing

Pharmacokinetics, Safety and Tolerability of Single Doses of BIIB033 (Opicinumab) Produced by 2 Manufacturing Processes

Who this might be right for
Multiple SclerosisAcute Optic Neuritis
Biogen 28
Not applicableStudy completedNCT00064909
What this trial is testing

MR Perfusion Imaging and Hypercapnia (Increased Carbon Dioxide) to Study New Blood Vessel Formation in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
National Institutes of Health Clinical Center (CC) 50
Early research (Phase 1)Looking for participantsNCT05620940
What this trial is testing

A Clinical Trial to Assess Pharmacokinetic Profiles, Safety and Tolerability of IVL3004 and IVL4002 in Healthy Male Subjects.

Who this might be right for
Opioid DependenceAlcohol DependenceMultiple Sclerosis
Inventage Lab., Inc. 40
Early research (Phase 1)Study completedNCT01738347
What this trial is testing

Assess Safety, Bio-distribution, Radiation Dosimetry and Optimize the Imaging Protocol of GEH120714 (18F) Injection in Healthy Volunteers and Participants With Relapsing and Remitting Multiple Sclerosis (rrMS).

Who this might be right for
Relapsing-remitting Multiple Sclerosis (rrMS)
GE Healthcare 30
Early research (Phase 1)Study completedNCT04022473
What this trial is testing

Study to Compare GI Tolerability Following Oral Administration of Bafiertam™ or Tecfidera to Healthy Volunteers

Who this might be right for
Multiple Sclerosis
Banner Life Sciences LLC 210
Early research (Phase 1)Study completedNCT01699555
What this trial is testing

First-in-Human Study With GNbAC1 in Healthy Volunteers

Who this might be right for
Multiple Sclerosis
GeNeuro Innovation SAS 33
Early research (Phase 1)Study completedNCT02452996
What this trial is testing

Safety Study of GNbAC1 Monoclonal Antibody in Healthy Male Volunteers

Who this might be right for
Healthy Volunteers
GeNeuro Innovation SAS 21
Early research (Phase 1)Study completedNCT06643390
What this trial is testing

MK-2225 in Healthy Participants (MK-2225-003)

Who this might be right for
Systemic Sclerosis
Merck Sharp & Dohme LLC 32
Next Page